Optic neuritis as an early sign of multiple sclerosis

References

• ShamsPNPlantGTOptic neuritis: a reviewInt MS J2009163828919878630
   PubMedGoogle Scholar
• Abou ZeidNBhattiMTAcute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerationsNeurologist200814420722318617847
   PubMed Web of Science ®Google Scholar
• BeckRWGalRLTreatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trialArch Ophthalmol2008126799499518625951
   PubMedGoogle Scholar
• BrodskyMNazarianSOrengo-NaniaSOptic Neuritis Study GroupMultiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-upArch Neurol20086572773218541792
   PubMedGoogle Scholar
• BalcerLJOptic neuritisN Engl J Med20063541273128016554529
   PubMed Web of Science ®Google Scholar
• AvasaralaJRClinically isolated syndrome–rethinking the diagnosisJ Neurol Sci20153531–2798025940324
   PubMed Web of Science ®Google Scholar
• Optic Neuritis Study GroupVisual function 15 years after optic neuritis: a final follow-up report from the optic neuritis treatment trialOphthalmology200811561079108217976727
   PubMed Web of Science ®Google Scholar
• BeckRWClearyPABacklundJCOptic Neuritis Study GroupThe course of visual recovery after optic neuritis: experience of the optic neuritis treatment trialOphthalmology199410111177117787800355
   PubMed Web of Science ®Google Scholar
• BeckRWClearyPAOptic Neuritis Study GroupRecovery from severe visual loss in optic neuritisArch Ophthalmol19931113300
   Google Scholar
• MenonVSaxenaRMisraRPhuljheleSManagement of optic neuritisIndian J Ophthalmol20115911712221350281
   PubMed Web of Science ®Google Scholar
• KeltnerJLJohnsonCACelloKEDontchevMGalRLBeckRWOptic Neuritis Study GroupVisual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 yearsArch Ophthalmol2010128333033720212204
   PubMedGoogle Scholar
• KeltnerJLJohnsonCASpurrJOBeckRWComparison of central and peripheral visual field properties in the optic neuritis treatment trialAm J Ophthalmol199912854355310577521
   PubMed Web of Science ®Google Scholar
• FangJPDonahueSPLinRHGlobal visual field involvement in acute unilateral optic neuritisAm J Ophthalmol199912855456510577522
   PubMed Web of Science ®Google Scholar
• TrobeJDBeckRWMokePSClearyPAContrast sensitivity and other vision tests in the optic neuritis treatment trialAm J Ophthalmol19961215475538610798
   PubMed Web of Science ®Google Scholar
• BalcerLJBaierMLCohenJAContrast letter acuity as a visual component for the multiple sclerosis functional compositeNeurology2003611367137314638957
   PubMed Web of Science ®Google Scholar
• DooleyMCForoozanROptic neuritisJ Ophthalmic Vis Res20105318218722737354
   PubMedGoogle Scholar
• MamarabadiMRazjouyanHMohammadiFMoghaddasiMAssessment of outcome predictors after first attack of optic neuritisCan J Neurol Sci20113888789522030428
   PubMed Web of Science ®Google Scholar
• SwantonJKFernandoKTDaltonCMEarly MRI in optic neuritis: the risk for disabilityNeurology200972654255019204264
   PubMed Web of Science ®Google Scholar
• LebrunCBensaCDebouverieMAssociation between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patientsArch Neurol200966784184619597085
   PubMedGoogle Scholar
• TintoréMRoviraARíoJNew diagnostic criteria for multiple sclerosis: application in first demyelinating episodeNeurology2003601273012525713
   PubMed Web of Science ®Google Scholar
• FrederiksenJLLarssonHBOlesenJCorrelation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritisActa Neurol Scand19928633173221414254
   PubMed Web of Science ®Google Scholar
• ChanWJRecent advances in optic neuritis related to multiple sclerosisActa Ophthalmol201190320320921486394
   PubMed Web of Science ®Google Scholar
• FrohmanECostelloFZivadinovROptical coherence tomography in multiple sclerosisLancet Neurol200651085386316987732
   PubMed Web of Science ®Google Scholar
• CostelloFCouplandSHodgeWQuantifying axonal loss after optic neuritis with optical coherence tomographyAnn Neurol200659696396916718705
   PubMed Web of Science ®Google Scholar
• LochnerPLeoneMACoppoLB-mode transorbital ultrasononography for the diagnosis of acute optic neuritis. A systematic reviewClin Neurophysiol2016127180380926024983
   PubMed Web of Science ®Google Scholar
• LennonVAWingerchukDMKryzerTJA serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisLancet200436494512106211215589308
   PubMed Web of Science ®Google Scholar
• MealyMAWhetstoneAOrmanGIzbudakICalabresiPALevyMLongitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosisJ Neurol Sci2015153551–2596326026942
   PubMed Web of Science ®Google Scholar
• BichuettiDBde CamargoASFalcãoABGonçalvesFFTavaresIMde OliveiraEMThe retinal nerve fiber layer of patients with neuromyelitis optica and chronic relapsing optic neuritis is more severely damaged than patients with multiple sclerosisJ Neuroophthalmol201333322022423917443
   PubMed Web of Science ®Google Scholar
• BennettJLde SezeJLana-PeixotoMNeuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomographyMult Scler201521667868825662342
   PubMed Web of Science ®Google Scholar
• Optic Neuritis Study GroupThe 5-year risk of MS after optic neuritis: experience of the optic neuritis treatment trialNeurology1997495140414139371930
   PubMed Web of Science ®Google Scholar
• GalRLVedulaSSBeckRCorticosteroids for treating optic neuritisCochrane Database Syst Rev20128CD001430
   Google Scholar
• RuprechtKKlinkerEDintelmannTRieckmannPGoldRPlasma exchange for severe optic neuritis treatment of 10 patientsNeurology2004631081108315452303
   PubMed Web of Science ®Google Scholar
• KeeganMPinedaAAMcClellandRLDarbyCHRodriguezMWeinshenkerBGPlasma exchange for severe attacks of CNS demyelination:predictors of responseNeurology20025814314611781423
   PubMed Web of Science ®Google Scholar
• RoesnerSAppelRGbadamosiJMartinRHeesenCTreatment of steroid-unresponsive optic neuritis with plasma exchangeActa Neurol Scand2012126210310822050360
   PubMed Web of Science ®Google Scholar
• HeiglFHettichRArendtRDurnerJKoehlerJMauchEImmunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patientsAtheroscler Suppl201314116717323357160
   PubMed Web of Science ®Google Scholar
• TselisAPerumalJCaonCTreatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenousimmuno-globulinEur J Neurol200815111163116718727675
   PubMed Web of Science ®Google Scholar
• RoedHGLangkildeASellebjergFA double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritisNeurology200564580481015753413
   PubMed Web of Science ®Google Scholar
• AtkinsEJDrews-BotschCDNewmanNJCalvettiOSwansonSBiousseVManagement of optic neuritis in Canada: survey of ophthalmologists and neurologistsCan J Neurol Sci200835217918418574931
   PubMed Web of Science ®Google Scholar
• JacobsLDBeckRWSimonJHIntramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study GroupN Engl J Med200034389890411006365
   PubMed Web of Science ®Google Scholar
• O’ConnorPKinkelRPKremenchutzkyMEfficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteriaMult Scler20091572873419482863
   PubMed Web of Science ®Google Scholar
• The PRISMS (Prevention of Relapses and Disability by Interferon-β 1a Subcutaneously in Multiple Sclerosis Study) Group and University of British Columbia MS\MRI Analysis GoupPRISMS-4: long term efficacy of interferon beta-1a in relapsing MSNeurology2001561628163611425926
   PubMed Web of Science ®Google Scholar
• KapposLPolmanCHFreedmanMSTreatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesNeurology2006671242124916914693
   PubMed Web of Science ®Google Scholar
• ComiGMartinelliVRodegherMPreCISe study groupEffect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trialLancet200937497001503151119815268
   PubMed Web of Science ®Google Scholar
• ComiGFilippiMBarkhofFEffect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study (ETOMS)Lancet20013571576158211377645
   PubMed Web of Science ®Google Scholar
• MiloRMillerARevised diagnostic criteria of multiple sclerosisAutoimmun Rev2014134–551852424424194
   PubMed Web of Science ®Google Scholar
• Gómez-MorenoMDíaz-SánchezMRamos-GonzálezAApplication of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Spanish cohort of patients with clinically isolated syndromesMult Scler2012181394421865413
   PubMed Web of Science ®Google Scholar
• TintoréMRoviraARíoJBaseline MRI predicts future attacks and disability in clinically isolated syndromesNeurology20066796897217000962
   PubMed Web of Science ®Google Scholar
• ChanJWEarly diagnosis, monitoring, and treatment of optic neuritisNeurologist2012181233122217611
   PubMed Web of Science ®Google Scholar
• KaleNManagement of optic neuritis as a clinically first event of multiple sclerosisCurr Opin Ophthalmol201223647247623014264
   PubMed Web of Science ®Google Scholar